|
[1]Beuers U.Hepatic overlap syndromes[J].J Hepatol, 2005, 42 (Suppl 1) :S93-99.
|
|
[2]Rust C, Beuers U.Overlap syndromes among autoimmune liver diseases[J].World J Gastroenterol, 2008, 14 (21) :3368-3373.
|
|
[3]Silveira MG, Lindor KD.Overlap syndromes with autoimmune hepatitis in chronic cholestatic liver diseases[J].Expert Rev Gastroenterol Hepatol, 2007, 1 (2) :329-340.
|
|
[4]Burak KW, Urbanski SJ, Swain MG.A case of coexisting primary biliary cirrhosis and primary sclerosing cholangitis:a new overlap of autoimmune liver diseases[J].Dig Dis Sci, 2001, 46 (9) :2043-2047.
|
|
[5]Durazzo M, Premoli A, Fagoonee S, et al.Overlap syndromes of autoimmune hepatitis:what is known so far[J].Dig Dis Sci, 2003, 48 (3) :423-430.
|
|
[6]Toyoda M, Yokomori H, Kaneko F, et al.Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome concomitant with systemic sclerosis, immune thrombocytopenic purpura[J].Intern Med, 2009, 48 (23) :2019-2023.
|
|
[7]Yokokawa J, Saito H, Kanno Y, et al.Overlap of primary biliary cirrhosis and autoimmune hepatitis:Characteristics, therapy, and long term outcomes[J].J Gastroenterol Hepatol, 25 (2) :376-382.
|
|
[8]Muratori L, Cassani F, Pappas G, et al.The hepatitic/cholestatic"overlap"syndrome:an Italian experience[J].Autoimmunity, 2002, 35 (8) :565-568.
|
|
[9]Floreani A, Rizzotto ER, Ferrara F, et al.Clinical course and outcome of autoimmune hepatitis/primary sclerosing cholangitis overlap syndrome[J].Am J Gastroenterol, 2005, 100 (7) :1516-1522.
|
|
[10]Olsson R, Glaumann H, Almer S, et al.High prevalence of small duct primary sclerosing cholangitis among patients with overlapping autoimmune hepatitis and primary sclerosing cholangitis[J].Eur J Intern Med, 2009, 20 (2) :190-196.
|
|
[11]Muratori P, Granito A, Pappas G, et al.The serological profile of the autoimmune hepatitis/primary biliary cirrhosis overlap syndrome[J].Am J Gastroenterol, 2009, 104 (6) :1420-1425.
|
|
[12]European Association for the Study of the Liver.EASL clinical practice guidelines:management of cholestatic liver diseases[J].J Hepatol, 2009, 51 (2) :237-267.
|
|
[13]Czaja AJ.Frequency and nature of the variant syndromes of autoimmune liver disease[J].Hepatology, 1998, 28 (2) :360-365.
|
|
[14]O'Brien C, Joshi S, Feld JJ, et al.Long-term follow-up of antimitochondrial antibody-positive autoimmune hepatitis[J].Hepatology, 2008, 48 (2) :550-556.
|
|
[15]Papamichalis PA, Zachou K, Koukoulis GK, et al.The revised international autoimmune hepatitis score in chronic liver diseases including autoimmune hepatitis/overlap syndromes and autoimmune hepatitis with concurrent other liver disorders[J].J Autoimmune Dis, 2007, 4:3.
|
|
[16]Neuhauser M, Bjornsson E, Treeprasertsuk S, et al.Autoimmune hepatitis-PBC overlap syndrome:a simplified scoring system J Clini Hepatol, June 2011, Vol.27, No.6may assist in the diagnosis[J].Am J Gastroenterol, 105 (2) :345-353.
|
|
[17]Kuiper EM, Zondervan PE, van Buuren HR.Paris criteria are effective in diagnosis of primary biliary cirrhosis and autoimmune hepatitis overlap syndrome[J].Clin Gastroenterol Hepatol, 8 (6) :530-534.
|
|
[18]Joshi S, Cauch-Dudek K, Wanless IR, et al.Primary biliary cirrhosis with additional features of autoimmune hepatitis:response to therapy with ursodeoxycholic acid[J].Hepatology, 2002, 35 (2) :409-413.
|
|
[19]Renou C, Bourliere M, Martini F, et al.Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome:complete biochemical and histological response to therapy with ursodesoxycholic acid[J].J Gastroenterol Hepatol, 2006, 21 (4) :781-782.
|
|
[20]Al-Chalabi T, Portmann BC, Bernal W, et al.Autoimmune hepatitis overlap syndromes:an evaluation of treatment response, long-term outcome and survival[J].Aliment Pharmacol Ther, 2008, 28 (2) :209-220.
|
|
[21]Alric L, Thebault S, Selves J, et al.Characterization of overlap syndrome between primary biliary cirrhosis and autoimmune hepatitis according to antimitochondrial antibodies status[J].Gastroenterol Clin Biol, 2007, 31 (1) :11-16.
|
|
[22]Chazouilleres O, Wendum D, Serfaty L, et al.Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome[J].J Hepatol, 2006, 44 (2) :400-406.
|
|
[23]Gunsar F, Akarca US, Ersoz G, et al.Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome[J].Hepatogastroenterology, 2002, 49 (47) :1195-1200.
|
|
[24]Heurgue A, Vitry F, Diebold MD, et al.Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis:a retrospective study of 115 cases of autoimmune liver disease[J].Gastroenterol Clin Biol, 2007, 31 (1) :17-25.
|
|
[25]Csepregi A, Rocken C, Treiber G, et al.Budesonide induces complete remission in autoimmune hepatitis[J].World J Gastroenterol, 2006, 12 (9) :1362-1366.
|
|
[26]Wiegand J, Schuler A, Kanzler S, et al.Budesonide in previously untreated autoimmune hepatitis[J].Liver Int, 2005, 25 (5) :927-934.
|
|
[27]Duclos-Vallée JC, Hadengue A, Ganne-Carrie N, et al.Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.Corticoresistance and effective treatment by cyclosporine A[J].Dig Dis Sci, 1995, 40 (5) :1069-1073.
|
|
[28]Kaya M, Angulo P, Lindor KD.Overlap of autoimmune hepatitis and primary sclerosing cholangitis:an evaluation of a modified scoring system[J].J Hepatol, 2000, 33 (4) :537-542.
|
|
[29]Johnson PJ, McFarlane IG.Meeting report:International Autoimmune Hepatitis Group[J].Hepatology, 1993, 18 (4) :998-1005.
|
|
[30]Alvarez F, Berg PA, Bianchi FB, et al.International Autoimmune Hepatitis Group Report:review of criteria for diagnosis of autoimmune hepatitis[J].J Hepatol, 1999, 31 (5) :929-938.
|
|
[31]Chandok N, Silveira MG, Lindor KD.Comparing the simplified and international autoimmune hepatitis group criteria in primary sclerosing cholangitis[J].Gastroenterol Hepatol (N Y) , 2010, 6 (2) :108-112.
|
|
[32]Mitchell SA, Bansi DS, Hunt N, et al.A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis[J].Gastroenterology, 2001, 121 (4) :900-907.
|
|
[33]Silveira MG, Lindor KD.High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis[J].J Hepatol, 2008, 48 (5) :692-694.
|
|
[34]Cullen SN, Rust C, Fleming K, et al.High dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis is safe and effective[J].J Hepatol, 2008, 48 (5) :792-800.
|
|
[35]Gregorio GV, Portmann B, Karani J, et al.Autoimmune hepatitis/sclerosing cholangitis overlap syndrome in childhood:a 16-year prospective study[J].Hepatology, 2001, 33 (3) :544-553.
|
|
[36]Rubel LR, Seeff LB, Patel V.Primary biliary cirrhosis-primary sclerosing cholangitis overlap syndrome[J].Arch Pathol Lab Med, 1984, 108 (5) :360-361.
|
|
[37]Jeevagan A.Overlap of primary biliary cirrhosis and primary sclerosing cholangitis-a rare coincidence or a new syndrome[J].Int J Gen Med, 2010, 3:143-146.
|
|
[38]Brunner G, Klinge O.A chronic destructive non-suppurative cholangitis-like disease picture with antinuclear antibodies (immunocholangitis) [J].Dtsch Med Wochenschr, 1987, 112 (38) :1454-1458.
|
|
[39]Sakauchi F, Mori M, Zeniya M, et al.Antimitochondrial antibody negative primary biliary cirrhosis in Japan:utilization of clinical data when patients applied to receive public financial aid[J].J Epidemiol, 2006, 16 (1) :30-34.
|
|
[40]Mendes F, Lindor KD.Antimitochondrial antibody-negative primary biliary cirrhosis[J].Gastroenterol Clin North Am, 2008, 37:479-484, viii.
|
|
[41]Li CP, Tong MJ, Hwang SJ, et al.Autoimmune cholangitis with features of autoimmune hepatitis:successful treatment with immunosuppressive agents and ursodeoxycholic acid[J].J Gastroenterol Hepatol, 2000, 15 (1) :95-98.
|
DownLoad: